ImmunoGen, Inc. announced that effective September 18, 2023, the company appointed Lauren White as Senior Vice President and designated her as the Company?s principal financial officer. ?Ms. White, age 44, joined ImmunoGen from C4 Therapeutics, where she had served as Chief Financial Officer, Treasurer, and Principal Accounting Officer since June 2021. Ms. White had previously served in roles of increasing responsibility at Novartis, most recently serving as Vice President and Global Head of Financial Planning and Analysis for the Novartis Institutes for BioMedical Research (NIBR) since July 2017.

Prior to this role, she launched Novartis? global health business unit as the unit?s Chief Financial Officer in Basel, Switzerland. Ms. White also served as the global head for Novartis?

Malaria franchise throughout Africa, Asia, and Latin America, and previously served in various strategy and marketing roles with Boston Consulting Group and General Electric. Ms. White received her Bachelor's degree from the Carroll School of Management at Boston College and a Master of Business Administration degree from Harvard Business School. Effective September 18, 2023, Renee Lentini, the Company?s Vice President, Finance and Chief Accounting Officer, ceased to be the Company?s principal financial officer but will continue in her role as principal accounting officer.